Citations

Clear

3 citation(s) found for "ZHANG, RAN".

Cell-type specific allelic dampening of sex-linked genes in sex chromosome aneuploidy
Filippova, G. N. , Sanger, Elliott M., MacDonald, James, Fang, He, Groneck, Camille, Takasaki, Masaya, Meleshko, A. N., Liu, Yajuan , Li, Gang , Dyke, Daniel Van, Gravholt, Claus H., Bammler, Theo K. , Young, Jessica E., Berletch, Joel B. , Van Dyke, Daniel, Gravholt, Claus H , Noble, William S , Deng, Xinxian , Berletch, Joel B , Sanger, Elliott, Fang, He, Ma, Wenxiu , ZHANG, RAN, Murry, Charles E. , Dyke, Daniel L. Van , Skakkebæk, Anne , Gravholt, Claus Højbjerg , Distèche, Christine M.

Mayo Clinic

No container title available | April 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.16.719032 | PMID 42079153 Get It

Common sex chromosome aneuploidies (SCAs) often present with cognitive and cardiovascular dysfunction in humans. To address SCA effects on gene expression and DNA methylation in relevant cell types, we differentiated neural precursor cells (NPCs) and cardiomyocytes (CMs) from human induced pluripotent stem cells (hiPSCs) with different numbers of sex chromosomes, including isogenic and independent lines. As expected, the expression of genes that escape X inactivation (escapees) mostly increases with the number of inactive X chromosomes (Xi). However, allelic analysis shows dampening of escapees specifically on the Xi in XXY compared to XX in both NPCs and CMs, revealing a novel type of dosage compensation in SCA. In contrast, Y-linked gene expression is higher in XXY versus XY NPCs, but the opposite is observed in CMs. This may explain the greater number of differentially expressed autosomal genes in NPCs versus CMs with an added Y chromosome, while effects of added X chromosomes are similar between cell types. Concordantly, changes in autosomal DNA methylation are mainly driven by the presence of a Y chromosome. These findings highlight the cell-type specificity of sex-linked and autosomal gene regulation in SCA conditions.
Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated with Prolonged Survival after Surgery
Li, Xinqun, Truty, Mark A., Chopin‐Laly, Xavier, Roife, David , Lin, E. , Thomas, Ryan M. , Katz, Matthew H. G. , Fleming, Jason B. , Kang, Ya’an , Zhang, Ran , Chatterjee, Deyali , Wang, Huamin , Katz, Matthew H G

Mayo Clinic

Clinical Cancer Research | October 22, 2014 | Volume: 20 | Issue: 24 | Pages: 6529-6540

10.1158/1078-0432.ccr-14-0970 | PMID 25336691 Get It

Abstract Purpose: To evaluate the relevance between lumican expression patterns and the clinical course of patients with pancreatic ductal adenocarcinoma (PDAC), and to investigate the role of lumican in PDAC progression. Experimental Design: One hundred thirty-one patient tumors were chosen for tissue microarray staining, and Cox regression analysis was used to test the associations between lumican expression and clinical, pathologic, and oncologic outcomes in all patients. Primary PDAC cells and recombinant human lumican protein were used to establish a working model to mimic the in vivo interactions between stromal lumican and PDAC cells. Using this model, we tested the effects of lumican on EGFR signaling via Akt and hypoxia-inducible factor-1α (HIF1α) and its subsequent influence on glucose consumption, lactate production, intracellular ATP, and apoptotic cell death. Results: Lumican was present in the stroma surrounding PDAC cells in roughly one-half of primary tumors and the direct xenografts. Patients with stromal lumican were associated with a profound reduction in metastatic recurrence after surgery and 3-fold longer survival than patients without stromal lumican. In PDAC cells, extracellular lumican reduced EGFR expression and phosphorylation through enhanced dimerization and internalization of EGFR and the resultant inhibition of Akt kinase activity. Lumican also reduced HIF1α expression and activity via Akt. PDAC cells with enhanced HIF1α activity were resistant to lumican-induced inhibition of glucose consumption, lactate production, intracellular ATP, and apoptosis. Conclusions: There is a positive association between stromal lumican in primary PDAC tumors and prolonged survival after tumor resection. Lumican plays a restrictive role in EGFR-expressing pancreatic cancer progression. Clin Cancer Res; 20(24); 6529–40. ©2014 AACR.
Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest
Sengupta, Sagar , Robles, Ana I. , Linke, Steven P. , Sinogeeva, Natasha I., Pedeux, Rémy , Ward, Irene M., Celeste, Arkady, Nussenzweig, André , Halazonetis, Thanos D. , Harris, Curtis C. , Zhang, Ran , Chen, Junjie

Mayo Clinic

The Journal of Cell Biology | September 13, 2004 | Volume: 166 | Issue: 6 | Pages: 801-813

10.1083/jcb.200405128 | PMID 15364958 Get It

Bloom's syndrome is a rare autosomal recessive genetic disorder characterized by chromosomal aberrations, genetic instability, and cancer predisposition, all of which may be the result of abnormal signal transduction during DNA damage recognition. Here, we show that BLM is an intermediate responder to stalled DNA replication forks. BLM colocalized and physically interacted with the DNA damage response proteins 53BP1 and H2AX. Although BLM facilitated physical interaction between p53 and 53BP1, 53BP1 was required for efficient accumulation of both BLM and p53 at the sites of stalled replication. The accumulation of BLM/53BP1 foci and the physical interaction between them was independent of γ-H2AX. The active Chk1 kinase was essential for both the accurate focal colocalization of 53BP1 with BLM and the consequent stabilization of BLM. Once the ATR/Chk1- and 53BP1-mediated signal from replicational stress is received, BLM functions in multiple downstream repair processes, thereby fulfilling its role as a caretaker tumor suppressor.